» Articles » PMID: 35280129

The Impact of Accelerated HF-rTMS on Canine Brain Metabolism: An [F]-FDG PET Study in Healthy Beagles

Overview
Journal Front Vet Sci
Date 2022 Mar 14
PMID 35280129
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Repetitive transcranial magnetic stimulation (rTMS) has been proven to be a useful tool for the treatment of several severe neuropsychiatric disorders. Accelerated (a)rTMS protocols may have the potential to result in faster clinical improvements, but the effects of such accelerated paradigms on brain function remain to be elucidated.

Objectives: This sham-controlled arTMS study aimed to evaluate the immediate and delayed effects of accelerated high frequency rTMS (aHF-rTMS) on glucose metabolism in healthy beagle dogs when applied over the left frontal cortex.

Methods: Twenty-four dogs were randomly divided into four unequal groups: five active ( = 8)/ sham ( = 4) stimulation sessions (five sessions in 1 day), 20 active ( = 8)/ sham ( = 4) stimulation sessions (five sessions/ day for 4 days), respectively. [F] FDG PET scans were obtained at baseline, 24 h poststimulation, after 1 and 3 months post the last stimulation session. We explicitly focused on four predefined regions of interest (left/right prefrontal cortex and left/right hippocampus).

Results: One day of active aHF-rTMS- and not sham- significantly increased glucose metabolism 24 h post-active stimulation in the left frontal cortex only. Four days of active aHF-rTMS only resulted in a nearly significant metabolic decrease in the left hippocampus after 1 month.

Conclusions: Like in human psychiatric disorders, active aHF-rTMS in healthy beagles modifies glucose metabolism, although differently immediately or after 1 month post stimulation. aHF-rTMS may be also a valid option to treat mentally disordered dogs.

Citing Articles

Editorial: Epilepsy in veterinary science.

Fischer A, Volk H Front Vet Sci. 2023; 10:1200311.

PMID: 37266380 PMC: 10230363. DOI: 10.3389/fvets.2023.1200311.

References
1.
George M, Nahas Z, Molloy M, Speer A, Oliver N, Li X . A controlled trial of daily left prefrontal cortex TMS for treating depression. Biol Psychiatry. 2000; 48(10):962-70. DOI: 10.1016/s0006-3223(00)01048-9. View

2.
Baeken C, Brem A, Arns M, Brunoni A, Filipcic I, Ganho-Avila A . Repetitive transcranial magnetic stimulation treatment for depressive disorders: current knowledge and future directions. Curr Opin Psychiatry. 2019; 32(5):409-415. PMC: 6688778. DOI: 10.1097/YCO.0000000000000533. View

3.
Park J, Wood J, Bondi C, Del Arco A, Moghaddam B . Anxiety Evokes Hypofrontality and Disrupts Rule-Relevant Encoding by Dorsomedial Prefrontal Cortex Neurons. J Neurosci. 2016; 36(11):3322-35. PMC: 4792942. DOI: 10.1523/JNEUROSCI.4250-15.2016. View

4.
Varrone A, Asenbaum S, Vander Borght T, Booij J, Nobili F, Nagren K . EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging. 2009; 36(12):2103-10. DOI: 10.1007/s00259-009-1264-0. View

5.
Dockx R, Peremans K, Vlerick L, Van Laeken N, Saunders J, Polis I . Anaesthesia, not number of sessions, influences the magnitude and duration of an aHF-rTMS in dogs. PLoS One. 2017; 12(9):e0185362. PMC: 5609759. DOI: 10.1371/journal.pone.0185362. View